Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
about
Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivoTargeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish.Gene Therapy Used in Cancer Treatment.
P2860
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Adenovirus-mediated hypoxia-ta ...... ng genes in vitro and in vivo.
@en
Adenovirus-mediated hypoxia-ta ...... ng genes in vitro and in vivo.
@nl
type
label
Adenovirus-mediated hypoxia-ta ...... ng genes in vitro and in vivo.
@en
Adenovirus-mediated hypoxia-ta ...... ng genes in vitro and in vivo.
@nl
prefLabel
Adenovirus-mediated hypoxia-ta ...... ng genes in vitro and in vivo.
@en
Adenovirus-mediated hypoxia-ta ...... ng genes in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Adenovirus-mediated hypoxia-ta ...... ing genes in vitro and in vivo
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2011.43
P577
2011-08-12T00:00:00Z